Fatal human respiratory disease associated with the 1918 pandemic influenza virus and
potentially pandemic H5N1 viruses is characterized by severe lung pathology, including …

Investigation of the human antibody response to influenza virus infection has been largely
limited to serology, with relatively little analysis at the molecular level. The 1918 H1N1 …

The proapoptotic PB1-F2 protein of influenza A viruses has been shown to contribute to
pathogenesis in the mouse model. Expression of full-length PB1-F2 increases the pathogenesis …

Influenza A viruses of avian origin represent an emerging threat to human health as the
progenitors of the next influenza pandemic. In recent years, highly pathogenic avian influenza …

Severe acute respiratory syndrome (SARS) caused by a novel human coronavirus (CoV),
designated SARS-CoV, is a highly contagious respiratory disease with the lungs as a major …

The 1918 influenza pandemic was exceptionally severe, resulting in the death of up to 50
million people worldwide. Here, we show which virus genes contributed to the replication and …

Influenza vaccines capable of inducing cross-reactive or heterotypic immunity could be an
important first line of prevention against a novel subtype virus. Influenza virus-like particles (…

Severe acute respiratory syndrome (SARS), caused by a novel coronavirus (CoV) known as
SARS-CoV, is a contagious and life-threatening respiratory illness with pneumocytes as its …

Background. Highly pathogenic avian influenza viruses of the H5N1 subtype continue to
cross the species barrier to infect humans and cause severe disease. It has been suggested …

Highly pathogenic influenza A viruses, including avian H5N1 viruses and the 1918 pandemic
virus, cause severe respiratory disease in humans and animals. Virus infection is followed …